BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19731750)

  • 1. [Venlafaxine-containing prolonged release: critical exchange?].
    Saussele T
    Med Monatsschr Pharm; 2009 Jul; 32(7):239. PubMed ID: 19731750
    [No Abstract]   [Full Text] [Related]  

  • 2. Wellbutrin versus generic bupropion.
    Med Lett Drugs Ther; 2008 Jul; 50(1290):54-5. PubMed ID: 18617874
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of depression with different formulations of venlafaxine: a comparative analysis.
    Olver JS; Burrows GD; Norman TR
    Hum Psychopharmacol; 2004 Jan; 19(1):9-16. PubMed ID: 14716706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical use of venlafaxine serology to uncover genetic rapid metabolism.
    Schaller JL; Behar D
    J Neuropsychiatry Clin Neurosci; 2001; 13(1):112-3. PubMed ID: 11207339
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose venlafaxine in delusional and severely depressed patients.
    Ruiz-Doblado S; Rueda-Villar T; Casillas-Lara L
    J Psychopharmacol; 2009 Sep; 23(7):859-60. PubMed ID: 18562440
    [No Abstract]   [Full Text] [Related]  

  • 6. Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatment.
    Wikell C; Eap CB; Josefsson M; Apelqvist G; Ahlner J; Baumann P; Bengtsson F
    Chirality; 2002 May; 14(4):347-50. PubMed ID: 11968077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venlafaxine: a new class of antidepressant.
    Hardy J; Argyropoulos S; Nutt DJ
    Hosp Med; 2002 Sep; 63(9):549-52. PubMed ID: 12357859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotension caused by therapeutic doses of venlafaxine: case report and proposed pathophysiological mechanisms.
    Alexandrino-Silva C; Nadalini Mauá FH; de Andrade AG; de Toledo Ferraz Alves TC
    J Psychopharmacol; 2008 Mar; 22(2):214-6. PubMed ID: 18208934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of sustained-release dosage form of Venlafaxine HCl using liquisolid technique.
    Khanfar M; Sheikh Salem M; Kaddour F
    Pharm Dev Technol; 2014 Feb; 19(1):103-15. PubMed ID: 23347382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic version of Wellbutrin XL.
    FDA Consum; 2007; 41(2):4. PubMed ID: 17590892
    [No Abstract]   [Full Text] [Related]  

  • 11. The comparison of brand-name and generic formulations of venlafaxine: a therapeutic drug monitoring analysis.
    Unterecker S; Proft F; Riederer P; Lauer M; Deckert J; Pfuhlmann B
    Ther Drug Monit; 2014 Apr; 36(2):269-72. PubMed ID: 24365982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative venlafaxine kinetics in overdose.
    Langford NJ; Martin U; Ruprah M; Ferner RE
    J Clin Pharm Ther; 2002 Dec; 27(6):465-7. PubMed ID: 12472987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent Venlafaxine-induced sinus tachycardia.
    Abozguia K; Chudley S; Gammage M
    Int J Cardiol; 2006 Oct; 113(1):E9-10. PubMed ID: 16989912
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioequivalence of venlafaxine modified-release capsule revisited with an innovative approach using experimental and predictive models.
    Goswami D; Khuroo AH; Gurule S; Kumar A; Monif T
    Bioanalysis; 2011 Jan; 3(1):31-43. PubMed ID: 21175365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    Bloem BR; Roofthooft DW; Lammers GJ; de Beaufort AJ; Brouwer OF
    Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1885-6; author reply 1886. PubMed ID: 14533505
    [No Abstract]   [Full Text] [Related]  

  • 16. Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder.
    Khazaal Y
    Ann Pharmacother; 2007 Feb; 41(2):359-60. PubMed ID: 17284507
    [No Abstract]   [Full Text] [Related]  

  • 17. Venlafaxine (Effexor): concerns about increased risk of fatal outcomes in overdose.
    Deshauer D
    CMAJ; 2007 Jan; 176(1):39-40. PubMed ID: 17167104
    [No Abstract]   [Full Text] [Related]  

  • 18. [Not neglecting therapy of depression in the elderly].
    MMW Fortschr Med; 2006 Apr; 148(16):56-7. PubMed ID: 16688953
    [No Abstract]   [Full Text] [Related]  

  • 19. Perceptual disturbances associated with low-dose bupropion sustained-release treatment.
    Liu CY; Chien YS
    J Clin Psychopharmacol; 2007 Oct; 27(5):543-4. PubMed ID: 17873707
    [No Abstract]   [Full Text] [Related]  

  • 20. Interchangeability of controlled release drugs.
    Savard D
    Can J Cardiol; 1996 Jan; 12(1):93. PubMed ID: 8595576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.